As of today (2024-04-23), Evoke Pharma's share price is $0.47. Evoke Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.77. Hence, Evoke Pharma's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for Evoke Pharma's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Evoke Pharma's highest Price to Tangible Book Ratio was 16.09. The lowest was 2.19. And the median was 6.73.
EVOK's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.31 * Ranked among companies with meaningful Price-to-Tangible-Book only.
A closely related ratio is called PB Ratio. As of today, Evoke Pharma's share price is $0.47. Evoke Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-0.77. Hence, Evoke Pharma's P/B Ratio of today is .
Evoke Pharma Price-to-Tangible-Book Historical Data
The historical data trend for Evoke Pharma's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Evoke Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evoke Pharma Price-to-Tangible-Book Distribution
For the Drug Manufacturers industry and Healthcare sector, Evoke Pharma's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Evoke Pharma's Price-to-Tangible-Book falls into.
Evoke Pharma Price-to-Tangible-Book Calculation
Evoke Pharma's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Evoke Pharma Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Evoke Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EVOK has been successfully added to your 